Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015750
Filing Date
2024-11-14
Accepted
2024-11-14 17:00:55
Documents
101
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akya-20240930x10q.htm   iXBRL 10-Q 2443869
2 EX-10.1 akya-20240930xex10d1.htm EX-10.1 118400
3 EX-31.1 akya-20240930xex31d1.htm EX-31.1 16126
4 EX-31.2 akya-20240930xex31d2.htm EX-31.2 16134
5 EX-32.1 akya-20240930xex32d1.htm EX-32.1 6819
6 EX-32.2 akya-20240930xex32d2.htm EX-32.2 7823
  Complete submission text file 0001558370-24-015750.txt   10622512

Data Files

Seq Description Document Type Size
7 EX-101.SCH akya-20240930.xsd EX-101.SCH 65536
8 EX-101.CAL akya-20240930_cal.xml EX-101.CAL 77356
9 EX-101.DEF akya-20240930_def.xml EX-101.DEF 255339
10 EX-101.LAB akya-20240930_lab.xml EX-101.LAB 547760
11 EX-101.PRE akya-20240930_pre.xml EX-101.PRE 444525
104 EXTRACTED XBRL INSTANCE DOCUMENT akya-20240930x10q_htm.xml XML 2021227
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

EIN.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40344 | Film No.: 241463987
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)